Within the last year
Within the past 3 years
1 - 6 of 6 articles
213 2 2 1 1 Leo E. Hollister Francis P. Motzenbecker Roger O. Degan Veterans Administration Hospital Palo Alto California Summary Ten of 11 patients abruptly switched to placebos after several months of high daily doses (300–600 mg, 8–20 times the usual therapeutic range) of chlordiazepoxide...
213 2 2 1 1 F. Hoffmeister Pharmakologischen Laboratorium der Farbenfabriken Bayer Wuppertal-Elberfeld Deutschland Zusammenfassung Promazin-Derivate (Chlorpromazin und 3-Propionyl-Promazin), die Perazin-Derivate 3-Propionyl-Perazin, 3-Butyryl-Perazin, 3-Chlor-Perazin und Perphenazin, weiterhin...
213 2 2 1 1 Nauttam J. Kothari John C. Saunders Nathan S. Kline Research Facility Rockland State Hospital Orangeburg N. Y. College of Physicians and Surgeons Columbia University New York City Summary In schizophrenic patients, 3 days treatment with phenothiazines or hydrazines prevented a...
213 2 2 1 1 Dr. Nathan R. Rosenthal John W. Mason Department of Neuroendocrinology Walter Reed Institute of Research Walter Reed Army Medical Center Washington 12 D. C. New Drug Branch, Department of Health, Education and Welfare Food and Drug Administration, Bureau of Medicine Washington 25 D....
Read and print from thousands of top scholarly journals.
Sign up with Facebook
Sign up with Google
Already have an account? Log in
Save this article to read later. You can see your Read Later on your DeepDyve homepage.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.